tiprankstipranks
Akebia Therapeutics (AKBA)
NASDAQ:AKBA
AKBA
Akebia Therapeutics
RESEARCH TOOLSreports
Want to see AKBA full AI Analyst Report?

Akebia Therapeutics (AKBA) Revenue

1,639 Followers
StatisticsMarket CapRevenue

Akebia Therapeutics Revenue

Akebia Therapeutics had a revenue of 53.54M in the quarter ending Mar 31, 2026, with -7.07%. This bring the company's revenue in the last twelve months to 232.40M, Increased -1.61%. In the fiscal year ending Dec 31, 2025, Akebia Therapeutics had annual revenue of 236.20M with 47.46% growth.
Revenue (ttm)
232.40M
Revenue Growth
25.69%
P/S Ratio
1.20
Revenue/Employee
$1,304,950
Employees
181
Market Cap
$284.35M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
236.20M76.02M+47.46%
Dec 31, 2024
160.18M-34.44M-17.70%
Dec 31, 2023
194.62M-97.86M-33.46%
Dec 31, 2022
292.48M80.83M+38.19%
Dec 31, 2021
211.65M-82.99M-28.17%
Dec 31, 2020
294.64M-40.36M-12.05%
Dec 31, 2019
335.00M127.26M+61.26%
Dec 31, 2018
207.74M29.76M+16.72%
Dec 31, 2017
177.98M――